Updated
Updated · BBC Science Focus · Aug 16
Nature Study Links 10 Years of Lithium Data to Lower Dementia Risk
Updated
Updated · BBC Science Focus · Aug 16

Nature Study Links 10 Years of Lithium Data to Lower Dementia Risk

2 articles · Updated · BBC Science Focus · Aug 16

Summary

  • Harvard-led researchers found significantly lower lithium levels in the prefrontal cortex of people with mild cognitive impairment or Alzheimer’s after analyzing 27 metals in post-mortem brains over 10 years.
  • Mouse experiments then suggested a mechanism: lithium bound Amyloid beta, and animals kept on lower lithium levels developed faster Alzheimer’s-like brain changes than mice with normal levels.
  • Lithium orotate performed better than lithium carbonate in mice because amyloid did not bind to it, reducing Alzheimer’s-like symptoms and pointing to a possible treatment avenue.
  • Human evidence remains weak: a small 2-year JAMA Neurology trial of lithium carbonate in people with mild cognitive impairment found no improvement in memory, thinking or MRI measures.
  • Researchers and outside experts said lithium is not yet proven to prevent dementia in humans, recommending established approaches such as Mediterranean-style diets and correcting vitamin D or B12 deficiencies.

Insights

With human trials failing but mouse models thriving, what hidden danger makes supplementing lithium for dementia a highly risky gamble today?
Why does the brain mysteriously starve of lithium while the rest of the body remains perfectly supplied during cognitive decline?